Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2012 Apr 6;261(2):181–188. doi: 10.1016/j.taap.2012.03.024

Figure 4.

Figure 4

EGCG increases expression of the phase II enzymes GST and NQO1. Expression of (A) GST and (B) NQO1 was analyzed in endothelial cells pretreated with 25–50 µM of EGCG for 3 h, followed by treatment with PCB 126 at 0.25 µM for 16 h. Real-time PCR technique was used to measure expressed mRNA levels. Results represent the mean ± SEM, with n=3. Experiments were repeated a minimum of three times. *Significantly different compared to DMSO control.

HHS Vulnerability Disclosure